NFKB1 and inflammatory bowel disease: To date a precise understanding of the effective dose, safe regimental therapy, and mechanism of action for the use of curcumin in the treatment of IBD is unknown, but there is abundant evidence proving its effects on the NF-κB pathway and p38 MAPK in the intestinal mucosa.